Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 230,962,814 papers from all fields of science
Search
Sign In
Create Free Account
natalizumab
Known as:
Anti-VLA4
, Anti-alpha4 integrin
, Natalizumab [Chemical/Ingredient]
A humanized recombinant IgG4 monoclonal antibody directed against the alpha4 subunit of the integrins alpha4beta1and alpha4beta7 with…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
12 relations
15 ML natalizumab 20 MG/ML Injection [Tysabri]
In Blood
Integrin alpha4
NCIt Antineoplastic Agent Terminology
Expand
Narrower (3)
Antegren
Tysabri
monoclonal antibody AN100226
Broader (1)
Immunologic Factors
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Progressive multifocal leukoencephalopathy and rheumatoid arthritis treatments.
G. Clavel
,
A. Moulignier
,
L. Semerano
Joint, bone, spine : revue du rhumatisme
2017
Corpus ID: 205756739
2011
2011
Delivery of healthy babies after natalizumab use for multiple sclerosis: a report of two cases
I. A. Hoevenaren
,
L. de Vries
,
R. Rijnders
,
F. Lotgering
Acta Neurologica Scandinavica
2011
Corpus ID: 22478975
Hoevenaren IA, de Vries LC, Rijnders RJP, Lotgering FK. Delivery of healthy babies after natalizumab use for multiple sclerosis…
Expand
2011
2011
Evolution of multiple sclerosis treatment: next generation therapies meet next generation efficacy criteria
H. Hartung
,
O. Aktas
Lancet Neurology
2011
Corpus ID: 10288226
Review
2008
Review
2008
Identification and development of new therapeutics for multiple sclerosis.
R. Linker
,
B. Kieseier
,
R. Gold
TIPS - Trends in Pharmacological Sciences
2008
Corpus ID: 366515
Review
2006
Review
2006
Multiple sclerosis, natalizumab therapy, and progressive multifocal leukoencephalopathy
R. Bartt
Current Opinion in Neurology
2006
Corpus ID: 3220360
Purpose of reviewMultiple sclerosis affects many people, often in early adulthood, and causes significant disability. Natalizumab…
Expand
2005
2005
Tunable antibodies
L. Weiner
,
P. Carter
Nature Biotechnology
2005
Corpus ID: 1147972
A recent Keystone meeting highlighted the progress in generating effective anti-cancer antibodies by manipulating antibody…
Expand
2004
2004
Poly(ethylene glycol)-polyacrylate copolymers modified to control adherent monocyte-macrophage physiology: interactions with attaching Staphylococcus epidermidis or Pseudomonas aeruginosa bacteria.
V. Wagner
,
J. Bryers
Journal of Biomedical Materials Research. Part A
2004
Corpus ID: 25796742
The ability of various surface modifications of poly(ethylene glycol)-graft-polyacrylate (PEG-g-PA) copolymers (tethered adhesion…
Expand
2003
2003
Monocyte/macrophage interactions with base and linear- and star-like PEG-modified PEG-poly(acrylic acid) co-polymers.
V. Wagner
,
J. Bryers
Journal of Biomedical Materials Research. Part A
2003
Corpus ID: 45561048
Poly(ethylene glycol):poly(acrylate) PEG-g-PA co-polymers were made that inhibited nonspecific protein and cellular adhesion. PEG…
Expand
1997
1997
Propolypeptide of von Willebrand Factor Is a Novel Ligand for Very Late Antigen-4 Integrin*
T. Isobe
,
Tetsuya Hisaoka
,
+5 authors
J. Takagi
Journal of Biological Chemistry
1997
Corpus ID: 22346458
We have previously reported that propolypeptide of von Willebrand factor (pp-vWF) promotes melanoma cell adhesion in a β1…
Expand
1997
1997
Tumor Necrosis Factor α-Induced Eosinophil Accumulation in Rat Skin Is Dependent on α4 Integrin/Vascular Cell Adhesion Molecule-1 Adhesion Pathways
M. Sanz
,
A. Hartnell
,
+7 authors
S. Nourshargh
1997
Corpus ID: 208492561
Tumor necrosis factor α (TNFα) is a cytokine implicated in the pathogenesis of numerous chronic and acute inflammatory conditions…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE